Oppenheimer Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Sell |
|
|||||
|
2025
Q1 | $5.66M | Buy |
|
|||||
|
2024
Q4 | $6.07M | Sell |
|
|||||
|
2024
Q3 | $9.17M | Sell |
|
|||||
|
2024
Q2 | $9.82M | Buy |
|
|||||
|
2024
Q1 | $11.7M | Sell |
|
|||||
|
2023
Q4 | $10.5M | Sell |
|
|||||
|
2023
Q3 | $9.41M | Sell |
|
|||||
|
2023
Q2 | $10.3M | Buy |
|
|||||
|
2023
Q1 | $9.46M | Buy |
|
|||||
|
2022
Q4 | $9.12M | Sell |
|
|||||
|
2022
Q3 | $8.28M | Buy |
|
|||||
|
2022
Q2 | $7.63M | Sell |
|
|||||
|
2022
Q1 | $10.2M | Buy |
|
|||||
|
2021
Q4 | $10.4M | Buy |
|
|||||
|
2021
Q3 | $10.8M | Sell |
|
|||||
|
2021
Q2 | $10.5M | Buy |
|
|||||
|
2021
Q1 | $8.06M | Buy |
|
|||||
|
2020
Q4 | $4.15M | Sell |
|
|||||
|
2020
Q3 | $3.87M | Sell |
|
|||||
|
2020
Q2 | $3.62M | Buy |
|
|||||
|
2020
Q1 | $2.37M | Sell |
|
|||||
|
2019
Q4 | $2.87M | Buy |
|
|||||
|
2019
Q3 | $2.45M | Sell |
|
|||||
|
2019
Q2 | $2.63M | Buy |
|
|||||
|
2019
Q1 | $2.52M | Sell |
|
|||||
|
2018
Q4 | $2M | Buy |
|
|||||
|
2018
Q3 | $2.38M | Sell |
|
|||||
|
2018
Q2 | $2.01M | Sell |
|
|||||
|
2018
Q1 | $2.23M | Buy |
|
|||||
|
2017
Q4 | $2.07M | Hold |
|
|||||
|
2017
Q3 | $2.07M | Buy |
|
|||||
|
2017
Q2 | $985K | Buy |
|
|||||
|
2017
Q1 | $444K | Buy |
|